BioDlink International Company Limited (HKG:1875)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Anti-tumor Drugs and Self-developed Biological Drugs	1.19B
Anti-tumor Drugs and Self-developed Biological Drugs Growth	38.05%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	1.18B
China Growth	36.30%
Other	15.08M